一批制造公众用药焦虑，引导购买高端医疗保险的账号被依法处置

Core Viewpoint - The recent actions by the Central Cyberspace Administration and the National Medical Insurance Administration aim to address and rectify false information related to centralized drug procurement, which has been misleading the public and creating unnecessary anxiety regarding medication choices [1] Group 1: Regulatory Actions - The Central Cyberspace Administration and the National Medical Insurance Administration have collaborated to tackle online misinformation regarding drug procurement [1] - A number of social media accounts have been identified and dealt with for spreading false narratives, including claims about "imported drugs collectively exiting China" [1] - Specific accounts, such as "成都XXX" on Weibo and "琼波XX" on Douyin, have been noted for distorting national policies and inciting public anxiety about original and generic drugs [1] Group 2: Impact on Public Perception - The misinformation has been aimed at creating a divide between original and generic drugs, which could lead to public confusion and anxiety regarding medication [1] - Some accounts have been found to promote the purchase of health products and high-end medical insurance, as well as directing the public to specific online platforms for drug purchases [1] - The actions taken against these accounts reflect a broader effort to protect public health and ensure accurate information dissemination in the pharmaceutical sector [1]